INS and COVID-19: Downstream analyses revealed valuable insights on T2D pathogenesis, including associations with other diabetes phenotypes and COVID-19 and patterns of tissue-specific and tissue non-specific differential gene expression as well as pathophysiological manifestations such as those related to insulin action, immunity, and apoptosis.